These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15741568)

  • 1. Vascular normalization: study examines how antiangiogenesis therapies work.
    Webb T
    J Natl Cancer Inst; 2005 Mar; 97(5):336-7. PubMed ID: 15741568
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies.
    Grothey A; Ellis LM
    Cancer J; 2008; 14(3):170-7. PubMed ID: 18536556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of angiogenesis by proteins, peptides and "small molecules"].
    Jayson G; Armand JP; Berdel WE
    Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103
    [No Abstract]   [Full Text] [Related]  

  • 4. Current overview of angiogenesis inhibitors.
    Ellis LM
    Clin Adv Hematol Oncol; 2004 Aug; 2(8):494-6, 520. PubMed ID: 16163228
    [No Abstract]   [Full Text] [Related]  

  • 5. The current STATe of biomarkers to predict the response to anti-angiogenic therapies.
    Tran PT; Felsher DW
    Cancer Biol Ther; 2008 Dec; 7(12):2004-6. PubMed ID: 19158482
    [No Abstract]   [Full Text] [Related]  

  • 6. A new weapon for attacking tumor blood vessels.
    Semenza GL
    N Engl J Med; 2008 May; 358(19):2066-7. PubMed ID: 18463385
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bevacizumab].
    Taéron C
    Rev Infirm; 2009; (147):46-8. PubMed ID: 19317091
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiogenesis of breast cancer.
    Schneider BP; Miller KD
    J Clin Oncol; 2005 Mar; 23(8):1782-90. PubMed ID: 15755986
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiogenesis. A boost for tumor starvation.
    Marx J
    Science; 2003 Jul; 301(5632):452-4. PubMed ID: 12881543
    [No Abstract]   [Full Text] [Related]  

  • 10. Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.
    Ferrara N; Hillan KJ; Novotny W
    Biochem Biophys Res Commun; 2005 Jul; 333(2):328-35. PubMed ID: 15961063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hoarseness during treatment with bevacizumab and other vascular endothelial growth factor signalling inhibitors.
    Wong H; Yau T; Man CW; Epstein RJ
    Acta Oncol; 2009; 48(8):1213-5. PubMed ID: 19863234
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-angiogenic and anti-HER therapy.
    Gasparini G; Sarmiento R; Longo R
    Biomed Pharmacother; 2006 Jul; 60(6):263-5. PubMed ID: 16815667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer. Encouraging results for second-generation antiangiogenesis drugs.
    Marx J
    Science; 2005 May; 308(5726):1248-9. PubMed ID: 15919970
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeted Therapies in Cancer - Fourth International Congress. Angiogenesis inhibition.
    Tawbi H; Agarwala SS
    IDrugs; 2005 Dec; 8(12):984-6. PubMed ID: 16320129
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast tumour angiogenesis.
    Fox SB; Generali DG; Harris AL
    Breast Cancer Res; 2007; 9(6):216. PubMed ID: 18190723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ramucirumab: a novel antiangiogenic agent.
    Wadhwa R; Taketa T; Sudo K; Blum-Murphy M; Ajani JA
    Future Oncol; 2013 Jun; 9(6):789-95. PubMed ID: 23718298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The new cancer blockers.
    Johns Hopkins Med Lett Health After 50; 2004 Oct; 17(8):1-2, 7. PubMed ID: 15602777
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting coagulation to the tumor microvasculature: perspectives and therapeutic implications from preclinical studies.
    Narazaki M; Tosato G
    J Natl Cancer Inst; 2005 May; 97(10):705-7. PubMed ID: 15900035
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angiogenesis inhibitors and radiation therapy: concept and preliminary results].
    Mazeron R; Bourhis J; Deutsch E
    Bull Cancer; 2009 Mar; 96(3):299-310. PubMed ID: 19318308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab for advanced breast cancer.
    Traina TA; Rugo HS; Dickler M
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):303-19. PubMed ID: 17512451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.